Insights from 2023 ASH Annual Meeting
Playback speed
10 seconds
ASH 2023 Insights: "BMS-986393 (CC-95266), an Autologous GPRC5D-Targeted CAR T-Cell Therapy for R/R MM - Ph1 Study Results"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Susan Bal
By
Insights from 2023 ASH Annual Meeting
FEATURING
Susan Bal
69 views
December 15, 2023
Comments 0
Login to view comments.
Click here to Login
Myeloma